Booster, Shots for Kids in the agenda that NTAGI meets today, Health News, ET HealthWorld

The National Technical Advisory Group on Immunization (NTAGI), a Covid-19 advisory group in India, has a need for booster immunization to eligible populations, booster doses for immunodeficiency, and a meeting to be held on Monday, people who know. Told ET.

NTAGI Chair NK Arora will give a presentation on the status report, detailing the proportion of children in all active Covid-19 cases, the impact of Covid-19 on children, and the need for vaccination of children. ..

The Union Health Minister has previously stated that the decision to vaccinate children will not be made in a hurry, and the government’s focus will be on all adults being vaccinated against Covid-19 prior to booster vaccination. It was to make sure that.

“It’s a child’s problem, so experts must be fully convinced. Developed countries that have begun vaccination of children are also carefully trampling, so great care must be taken. Expert decisions are final. It will be something like this. ” Minister Mansukh Mandaviya said in an exchange with the media.

Currently, only Zydus Healthcare’s Covid-19 vaccine, ZyCoV-D, has been approved for emergency use in India for children 12 years and older. Indian drug regulators are still considering an emergency use of Bharat Biotech’s Covaxin for people over two years. It has been approved by the Subject Expert Committee under the Drug Regulatory Authority.

According to people familiar with the development, even if an agreement is reached among NTAGI members to start vaccination of children, vaccination will be provided to children with comorbidities first. Government experts will also soon publish a list of comorbidities that may determine which children are first eligible for the vaccine. This list may include cancer treatments, transplant cases, and immunocompromised children, among others.

As the Omicron variant penetrates the country, the debate over booster doses has intensified, and NTAGI may discuss this issue.

The same people said that an important decision on whether immunocompromised people should receive an additional third dose of the Covid-19 vaccine may also be discussed on Monday.

In India, Insacog, a consortium of genomic sequencing laboratories, has the potential for additional doses of the Covid-19 vaccine in high-risk populations, given new evidence from South Africa and several other countries. We discussed the role earlier.

Booster, Shots for Kids in the agenda that NTAGI meets today, Health News, ET HealthWorld

Source link Booster, Shots for Kids in the agenda that NTAGI meets today, Health News, ET HealthWorld

Related Articles

Back to top button